Health & Safety Guidance

New guidelines (published 18 Nov 2021) from the Advisory Committee for Dangerous Pathogens (ACDP) TSE subgroup state that no additional precautions are needed for handling CSF, blood, saliva, and urine samples from patients with suspected Creutzfeldt-Jakob disease (CJD), beyond standard CSF protocols.

Guidelines for high-risk materials like brain and nervous tissue remain unchanged.

Part 3: Laboratory containment and control measures guidance: ACDP TSE Subgroup Guidelines (PDF)